Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
PowerShares Dynamic Biotech & Genome (PBE)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Comments
News & PR
Market Currents
Buzz
Twitter: PBE
Coverage
Top Authors
Cramer
Top Analysts
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
ETF Stats for PBE
Expense Ratio:
0.62%
Average Bid Ask Ratio:
0.13%
Tracking Error:
0.64%
Concentration Risk:
9.90%
Capital Gains Dist. %:
0.00%
Number of Securities:
30
Dividend Amount:
Dividend Date:
For overall rating and ranking versus other ETFs get a
free trial
to
XTF Premium
Analysis - Latest Articles
Biotech Investing: Spreading the Risk with ETFs
Tom Lydon
•
Nov 22
•
1 Comment
What Biotechnology ETFs Need to Thrive
Tom Lydon
•
Sep 07
•
Comment!
Healthcare ETFs Headed for Life Support?
Michael Johnston
•
Aug 16
•
2 Comments
7 Reasons Biotech ETFs Could Succeed
Tom Lydon
•
Aug 06
•
Comment!
ETF Spotlight: PowerShares Dynamic Biotech & Genome (PBE)
Tom Lydon
•
Jul 31
•
Comment!
Global Markets in Review: Are Markets Discounting Bernanke's Scenario?
Prieur du Plessis
•
Jul 26
•
22 Comments
More articles on PBE »
Instablogs
Stem Cell Index: YTD Analysis, Banking on NeoStem
Sat April 11, 2009
•
Mike Havrilla
•
Comment!
Write a post on PBE
|
More Instablogs on PBE »
What's your view of PBE?
Make sure you include PBE
140 characters left
|
Settings